John King named commercial head at Dianthus
Plus: CMO Laura Gault steps down at Sage, and updates from Orbis and Nature’s Toolbox
Autoimmune diseases company Dianthus Therapeutics Inc. (NASDAQ:DNTH) hired John King as chief commercial officer. King was most recently CCO, head of business development at Vor Biopharma Inc. (NASDAQ:VOR). Additionally, Sujay Kango, former president and CEO of Tmunity Therapeutics Inc., joined the board. Dianthus is developing antibodies for neuromuscular indications. Top-line data from a Phase II trial in myasthenia gravis are expected in 2H25.
Following a wave of leadership departures in October, Laura Gault is stepping down as CMO of Sage Therapeutics Inc. (NASDAQ:SAGE). The CNS-focused company is weighing its future after a series clinical and regulatory misses and its recent rejection of a takeout offer from partner Biogen Inc. (NASDAQ:BIIB)...